Regal Investment Advisors’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.13M Sell
106,954
-6,387
-6% -$280K 0.3% 88
2025
Q4
$4.38M Buy
113,341
+3,617
+3% +$138K 0.26% 97
2025
Q3
$3.87M Buy
109,724
+16,792
+18% +$608K 0.25% 107
2025
Q2
$3.35M Sell
92,932
-6,772
-7% -$224K 0.25% 105
2025
Q1
$3.1M Buy
99,704
+81,989
+463% +$2.6M 0.25% 111
2024
Q4
$452K Sell
17,715
-11,138
-39% -$295K 0.03% 342
2024
Q3
$816K Buy
28,853
+7,686
+36% +$213K 0.06% 276
2024
Q2
$558K Buy
21,167
+3,700
+21% +$103K 0.04% 332
2024
Q1
$530K Buy
17,467
+7,960
+84% +$235K 0.04% 349
2023
Q4
$267K Buy
+9,507
New +$261K 0.02% 444
2023
Q2
Sell
-5,749
Closed -$207K 544
2023
Q1
$207K Buy
5,749
+29
+0.5% +$1.07K 0.02% 477
2022
Q4
$226K Buy
5,720
+270
+5% +$11.3K 0.02% 431
2022
Q3
$219K Buy
+5,450
New +$233K 0.02% 427

Other funds holding RPRX